NUVBNuvation Bio Inc.
$4.57+26% 1Y
$4.57
$3.4152 weeks$9.54
Is the business good?
How good a business is NUVB?
Nuvation Bio Inc. keeps −81% of every revenue dollar as operating profit, against −82% for the median Biotechnology name.
−81%
Operating margin · Biotechnology median −82% · 12 months to Q2 2026
- R&D as % of revenue
- 76%
R&D as % of revenue
Details›
- Operating margin12 months to Q2 2026
- −81%
- Net margin12 months to Q2 2026
- −88%
- Free cash flow margin
- −128%
- R&D as % of revenue
- 76%
- Revenue, trailing twelve months
- $170M
- Free cash flow, trailing twelve months
- −$217M
- Net income, trailing twelve months
- −$150M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
On our screens:Most shorted stocks